Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer
Condition(s):Urinary Bladder CancerLast Updated:April 25, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Urinary Bladder CancerLast Updated:April 25, 2023Recruiting
Condition(s):Locally Advanced CholangiocarcinomaLast Updated:February 7, 2024Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:September 5, 2018Unknown status
Condition(s):Bile Duct CancerLast Updated:February 24, 2022Completed
Condition(s):Malignant Solid TumorLast Updated:September 30, 2019Completed
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Gene RearrangementsLast Updated:January 9, 2024Active, not recruiting
Condition(s):Durvalumab; Intrahepatic Cholangiocarcinoma; GemcisLast Updated:January 5, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:June 27, 2016Completed
Condition(s):Genital Neoplasms, MaleLast Updated:March 31, 2015Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:March 8, 2011Suspended
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.